This is the enzyme responsible for converting testosterone into DHT
Thus far, approximately 40 companies worldwide, including Codiak Biosciences, Evox Therapeutics, Tavec Pharmaceuticals, Carmine Therapeutics, Anjarium, and Micromedmark Biotech, have developed exosome-based therapies, which are expected to provide cost-effective and more accurate targeted therapies in the clinic ( However, challenges, such as large-scale production, purity, and batch homogeneity of exosomes, still limit their clinical application
Despite having sulfate in the name, it isnt a surfactant or cleansing agent like sodium lauryl sulfate
Carabotti M et al
is a Scholar of the Leukemia and Lymphoma Society and is supported by the US NIH NIDDK R01-DK101989-01A1